This site is for u.s. healthcare professionals only

ThIs site is for U.S. healthcare professionals only


AURYXIA® (ferric citrate) brought patients within KDOQI serum phosphorus target range (3.5-5.5 mg/dL)1 with an average of 8-9 tablets per day over a year of treatment


Film-coated tablet designed to be swallowed not chewed


  • Each AURYXIA tablet contains 210 mg of ferric iron, equivalent to 1 g of ferric citrate


Prescribing non-calcium, non-chewable AURYXIA for the management of hyperphosphatemia in your adult patients with CKD on dialysis


Notes about titration with AURYXIA

  • Starting dose of 2 tablets 3 times per day with meals
  • AURYXIA can be titrated in increments or decrements of 1 to 2 tablets per day to maintain serum phosphorus target levels. Titrate at 1-week or longer intervals
  • Maximum dose: 12 tablets daily